TPA Patient Information Sheet - Boston Medical Center - bmc 2026

Get Form
TPA Patient Information Sheet - Boston Medical Center - bmc Preview on Page 1

Here's how it works

01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

Definition & Meaning

The TPA Patient Information Sheet - Boston Medical Center - bmc is a critical document provided to patients who may be eligible for treatment with tissue Plasminogen Activator (tPA). This medication is used to dissolve blood clots in patients experiencing ischemic strokes. The information sheet outlines the purpose and function of tPA, detailing how it should be administered within 4.5 hours of symptom onset for optimal effectiveness. It also covers scenarios where tPA might not be suitable and includes sections for understanding the associated risks and benefits.

How to Use the TPA Patient Information Sheet

The information sheet serves as an educational resource for both patients and healthcare providers. Patients should read the document thoroughly to understand the treatment process and make informed decisions. It explains the conditions under which tPA is applied, the potential risks involved, and necessary precautions. Moreover, patients are encouraged to discuss any concerns or questions with their healthcare provider after reviewing the sheet to ensure comprehensive understanding.

How to Obtain the TPA Patient Information Sheet

Patients visiting Boston Medical Center can acquire the TPA Patient Information Sheet directly from their healthcare provider during consultation. It may also be available digitally through Boston Medical Center’s official website or patient portal, allowing for easy access and review prior to appointments. Patients are advised to inquire about the sheet during initial discussions about stroke treatment options.

Steps to Complete the TPA Patient Information Sheet

If a form completion is necessary for acknowledgment or consent, patients should follow these steps:

  1. Read Thoroughly: Understand each section concerning tPA treatment.
  2. Consult the Healthcare Provider: Ask any questions or express concerns regarding the treatment.
  3. Acknowledge Risks and Benefits: Make note of the potential risks and benefits as outlined.
  4. Provide Informed Consent: Sign the consent section (if applicable), confirming understanding and agreement to proceed.
  5. Submit to Healthcare Provider: Return the completed form to the healthcare provider for processing.

Key Elements of the TPA Patient Information Sheet

The information sheet is composed of several critical elements:

  • Purpose of tPA Treatment: Explanation of how tPA works and its role in stroke management.
  • Administration Guidelines: Instructions regarding the administration time frame.
  • Risk Factors: Comprehensive list of potential risks and adverse effects.
  • Patient Eligibility: Criteria determining who can receive tPA.
  • Consent Form: Section for patients to acknowledge understanding and agree to treatment.

Legal Use of the TPA Patient Information Sheet

The document serves a legal function by ensuring informed consent, where patients are educated about their treatment options and agree to the use of tPA. It complies with medical and ethical standards, providing a means for healthcare providers to document informed agreement and manage associated liabilities. The information sheet is an essential part of the medical record, reflecting the patient’s understanding and the provider’s duty of care.

Who Typically Uses the TPA Patient Information Sheet

Primarily, the information sheet is used by patients experiencing symptoms of an ischemic stroke, alongside their families and caregivers. Medical professionals, such as doctors, nurses, and stroke specialists, utilize this document to guide discussions with patients and ensure they receive accurate and comprehensive information about tPA treatment.

decoration image ratings of Dochub

Important Terms Related to TPA Patient Information Sheet

  • Ischemic Stroke: A type of stroke caused by a blockage in the blood supply to the brain.
  • Thrombolytic Medication: A drug that helps dissolve blood clots.
  • Informed Consent: A process ensuring patients are fully informed before agreeing to a medical procedure.
  • Adverse Effects: Possible negative reactions to medication or treatment.

State-Specific Rules for the TPA Patient Information Sheet

While the general use and administration of tPA are standardized, specific legal requirements or protocols might vary by state. Boston Medical Center adheres to Massachusetts state regulations and medical guidelines, ensuring that the information sheet complies with local laws. Patients receiving treatment outside of Massachusetts should verify whether additional state-specific consent forms or procedures apply.

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
State patient record retention policies StateStatuteRetention Period California Cal. Code Regs. . 16, 1367.6 7 years Colorado Colo. Rev. Stat. 25-1-802 10 years Connecticut Conn. Gen. Stat. 52-146d 7 years Delaware 16 Del. Admin. Code 4463 7 years46 more rows Mar 27, 2023
It is not a HIPAA violation to email medical records provided the communication is permitted by the HIPAA Privacy Rule, that safeguards are in place to comply with the HIPAA Security Rule, and if emailing medical records to a patient that the patient has consented to receiving PHI by email.
Release of Information Service Address: Boston Medical Center, 850 Harrison Avenue (Yawkey Basement), Boston, MA 02118. Phone: 617.414.4213. Hours: Monday-Friday 8 a.m. to 4:30 p.m. Interpreter Services: For interpreter services or any assistance, please call 617.414. 5549.
For patients with a body weight of 100 kilograms or less, the recommended regimen is 0.09 mg/kg (10% of the total 0.9 mg/kg dose) administered as an IV bolus over 1 minute, followed by 0.81 mg/kg (90% of the 0.9 mg/kg dose) as a continuous infusion over 60 minutes.
Boston Medical Center As a premier academic medical center in Boston, a national leader in health equity, and the largest essential hospital in New England, BMC and its world-class clinicians provide comprehensive care in more than 70 specialties and subspecialties.

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more
ccpa2
pci-dss
gdpr-compliance
hipaa
soc-compliance

People also ask

(IV r-tPA) within 4.5 hours of stroke onset remains the standard of care for most ischemic stroke patients.
0:04 0:28 Once youve logged. In select request records complete the requester. Information and the type ofMoreOnce youve logged. In select request records complete the requester. Information and the type of record.

Related links